Compounds and anti-tumor NQO1 substrates

Paul J Hergenrother; David A. Boothman; Joseph S. Bair; Rahul Palchaudhuri; Elizabeth I. Parkinson

Compounds and anti-tumor NQO1 substrates

Paul J Hergenrother (Inventor)
, David A. Boothman (Inventor)
, Joseph S. Bair (Inventor)
, Rahul Palchaudhuri (Inventor)
, Elizabeth I. Parkinson (Inventor)

Research output: Patent

Abstract

Compounds of Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compounds are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.

Original language	English (US)
U.S. patent number	9611266
Filing date	1/11/16
State	Published - Apr 4 2017

Library availability

Discover UIUC Full Text

Cite this

@misc{94500346181c473eb04542ad11c69b55,

title = "Compounds and anti-tumor NQO1 substrates",

abstract = "Compounds of Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compounds are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.",

author = "Hergenrother, \{Paul J\} and Boothman, \{David A.\} and Bair, \{Joseph S.\} and Rahul Palchaudhuri and Parkinson, \{Elizabeth I.\}",

note = "GOVERNMENT SUPPORT This invention was made with government support under contract number CA102792 awarded by the National Institutes of Health. The government has certain rights in the invention.; 9611266",

year = "2017",

month = apr,

day = "4",

language = "English (US)",

type = "Patent",

}

TY - PAT

T1 - Compounds and anti-tumor NQO1 substrates

AU - Hergenrother, Paul J

AU - Boothman, David A.

AU - Bair, Joseph S.

AU - Palchaudhuri, Rahul

AU - Parkinson, Elizabeth I.

N1 - GOVERNMENT SUPPORT This invention was made with government support under contract number CA102792 awarded by the National Institutes of Health. The government has certain rights in the invention.

PY - 2017/4/4

Y1 - 2017/4/4

N2 - Compounds of Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compounds are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.

AB - Compounds of Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compounds are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.

M3 - Patent

M1 - 9611266

Y2 - 2016/01/11

ER -

Compounds and anti-tumor NQO1 substrates

Abstract

Library availability

Fingerprint

Cite this